Established on September 1, 2012, the Breast Surgery Department is a core subspecialty of the National Clinical Key Specialty—General Surgery. Under the leadership of Department Director and Doctoral Supervisor Dr. Peifen Fu, the department operates wards across three campuses: Qingchun, Zhijiang, and Yuhang. Over the past decade, we have evolved into a premier center for breast disease diagnosis and treatment in Zhejiang Province and a first-class institution in China. We are a specialized multidisciplinary oncology department dedicated to integrating clinical care with basic and translational research. With an annual outpatient volume exceeding 70,000 visits and treating over 2,000 breast cancer cases each year, we have earned the trust of patients across the province and the entire country.

Our department is staffed by 35 surgeons, all of whom have completed extensive training in multiple subspecialties and advanced surgical techniques. The team comprises 3 Chief Physicians, 9 Associate Chief Physicians, 13 Attending Physicians, 2 Doctoral Supervisors, and 31 staff members holding doctoral degrees.

Here is the revised translation. I have replaced "first" with "pioneered the introduction" and "pioneered the implementation," which indicate leading and innovation without explicitly claiming to be the absolute "first."

The department has established a comprehensive, standardized treatment system with distinct clinical features. We pioneered the introduction of advanced technologies in the province, including various types of endoscopic breast surgeries, breast-conserving surgery, sentinel lymph node biopsy, stage I and II breast reconstruction, chemotherapy port implantation, and minimally invasive vacuum-assisted biopsy for breast masses. The department also pioneered the implementation of the concept of comprehensive breast cancer treatment and full-cycle management. Placing a high value on aesthetic outcomes, we have incorporated oncoplastic techniques and perform cosmetic surgeries such as breast reduction, correction of inverted nipples, and correction of post-surgical deformities. In addition to surgical treatment, the department specializes in chemotherapy, endocrine therapy, and biological therapy.

The department undertakes numerous research projects, including those funded by the National Natural Science Foundation of China and the Zhejiang Provincial Outstanding Youth Science Foundation. Our surgeons and researchers have published multiple high-quality papers in renowned international journals. Furthermore, we have established a tissue bank and a comprehensive follow-up system, providing valuable clinical resources for research. Additionally, the department leads and participates in various multicenter clinical studies.

1.One of the First Batch of Top 10 Breast-Conserving Surgery Demonstration Centers Designated by the Breast Cancer Professional Committee of the Chinese Anti-Cancer Association

2.Breast Disease Standardized Diagnosis & Minimally Invasive Surgery Training Center

3.Breast Endoscopy Appropriate Technology Promotion Group / Breast Endoscopy Surgery Clinical Research Collaboration Group

4.Co-Chair Unit of China Alliance for Organ Preservation in Oncology & Breast (Morphology) Preservation Alliance

5.Breast-Conserving Surgery Demonstration Center of the Breast Cancer Society, Chinese Anti-Cancer Association

6.Standardized Diagnosis and Treatment Guidance Center for Breast Cancer of the Chinese Society of Clinical Oncology (CSCO)

7.Clinical Education Base for Venous Access Port